Amlodipine And Valsartan Tablet, Film Coated
Product Images NDC 65862-739

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Amlodipine And Valsartan (NDC 65862-739). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Probability Of Achieving Systolic Blood Pressure <140 Mmhg At Week 8 (Amlo Val Fig1)

This is a medical document related to the combination of two drugs, Amiodipine and Valsarian Tablets with strengths of 10mg/320mg respectively, used to treat hypertension (high blood pressure). The document presents a graph indicating the probability of achieving a systolic blood pressure of less than 140 mmHg at week 8. The graph shows the probability of achieving the target blood pressure for different values of baseline systolic blood pressures ranging from 140 to 180 mmHg. A placebo group is also included.*

FDA Label Image

Package Label-principal Display Panel (5 mg/320 mg Blister Carton (3 x 10 Unit-dose))

Amlodipine and Valsartan Tablets USP are Rx only tablets that come in a 5mg/320mg dosage strength. They are distributed by Aurobindo Pharma USA, Inc. and contain 30 (3x10) unit-dose tablets. Each film-coated tablet contains 6.9 mg of amlodipine besylate USP equivalent to 5 mg amlodipine and valsartan USP 320 mg. The tablets are made in India and the NDC number is 65862-738-03.*

FDA Label Image

Package Label-principal Display Panel (10 mg/320 mg (30 Tablets Bottle))

Amlodipine and Valsartan Tablets USP with NDC 65862-740-30 are prescription drugs that contain 10 mg of Amlodipine besylate USP and 320 mg of Valsartan USP. These tablets are film-coated and made in India. The package contains 30 tablets distributed by Aurobindo Pharma USA, Inc. The usual dosage can be found in the package insert. It is recommended to store them at 20° to 25°C and protect them from moisture. The text also includes a warning to keep all drugs out of the reach of children. The USP Organic Impurities Test is still pending.*

FDA Label Image

Package Label-principal Display Panel (10 mg/320 mg Blister Carton (3 x 10 Unit-dose))

This is a product description of Amlodipine and Valsartan Tablets USP manufactured in India and distributed under Aurobindo Pharma. Each unit-dose tablet contains 10 mg of Amlodipine and 320 mg of Valsartan. The tablets come in a box that contains 30 (3 x 10) unit-dose tablets. The manufacturer's information, including its address, is visible on the packaging label alongside the product code.*

FDA Label Image

Figure 2: Probability Of Achieving Diastolic Blood Pressure <90 Mmhg At Week 8 (Amlo Val Fig2)

This is a figure chart showing the probability of achieving diastolic blood pressure less than 90 mmHg at Week 8 for patients taking Amiodipine and Valsartan Tablets 10 mg/320 mg. The chart also shows baseline DBP values ranging from 100 to 110 mmHg. There is no additional information available in the text.*

FDA Label Image

Figure 3: Probability Of Achieving Systolic Blood Pressure <130 Mmhg At Week 8 (Amlo Val Fig3)

The text describes a figure showing the probability of achieving a systolic blood pressure of less than 130 mmHg after 8 weeks of taking Amlodipine and Valsartan tablets, Valsartan 320 mg, Amiodipine 10 mg, or a placebo. The figure shows baseline SBP levels ranging from 140 to 180 mmHg.*

FDA Label Image

Figure 4: Probability Of Achieving Diastolic Blood Pressure <80 Mmhg At Week 8 (Amlo Val Fig4)

This is a description of the probability of achieving Diastolic Blood Pressure <80 mmHg at Week 8 using Amlodipine and Valsartan Tablets 10 mg/320 mg. The figure shows the percentage of patients achieving this goal based on a baseline DBP(mmHg) of 100, 105, and 110. Placebo is also mentioned.*

FDA Label Image

Package Label-principal Display Panel (5 mg/160 mg (30 Tablets Bottle))

FDA Label Image

Package Label-principal Display Panel (5 mg/160 mg Blister Carton (3 x 10 Unit-dose))

Amlodipine and Valsartan Tablets USP are used to treat high blood pressure. Each film-coated tablet contains 6.9 mg of amodipine besylats USP equivalent o 5 mg amlodipine and valsartan. The medication is made in India and comes in a pack of 30 (3 x 10) unit-dose tablets. The provided NDC number is 65862-737-03.*

FDA Label Image

Package Label-principal Display Panel (5 mg/160 mg Blister Carton (3 x 10 Unit-dose))

FDA Label Image

Package Label-principal Display Panel (10 mg/160 mg Blister Carton (3 x 10 Unit-dose))

Amlodipine and Valsartan Tablets USP are a prescription medication containing 10 mg of amlodipine and 160 mg of valsartan. Each film-coated tablet contains 13.0 mg of amlodipine besylate USP equivalent to 10 mg amlodipine and valsartan USP 160 mo. The tablets are distributed by Aurobindo Pharma USA, Inc. in East Windsor, New Jersey. The package contains 30 (3 x 10) unit-dose tablets and the product is made in India.*

FDA Label Image

Package Label-principal Display Panel (5 mg/320 mg (30 Tablets Bottle))

Amlodipine and Valsartan Tablets USP, 5 mg/320 mg, manufactured by Aurobindo Pharma USA Inc. Each film-coated tablet consists of 6.9 mg of amlodipine besylate USP, equivalent to 5 mg amlodipine and valsartan USP 320 mg. The medication is for prescription only, and dosage information can be found on the package insert. It should be stored at 20-25°C (68-77°F) to protect from moisture, and kept out of reach of children. USP Organic Impurities Test is still pending. The code is TS/DRUGS/2212009.*

FDA Label Image

Chemical Structure1 (Amlo Val Str1)

FDA Label Image

Chemical Structure2 (Amlo Val Str2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.